Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05797155 · ClinicalTrials.gov registry record · NA
A Mobile App Based Cognitive Dissonance Intervention for Smoking Cessation
A NA study of Tobacco Use, sponsored by Oregon Research Behavioral Intervention Strategies.
- Completed
- Registry status
- NA
- Development phase
- 437
- Enrollment target
- 1
- Study location
NCT05797155: Completed NA study of Tobacco Use, sponsored by Oregon Research Behavioral Intervention Strategies.
NCT05797155 is a NA study of Tobacco Use that has completed, run by Oregon Research Behavioral Intervention Strategies. The registered enrollment target is 437 participants, above the 373-participant average among 76 other Tobacco Use trials with a reported enrollment target (17% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05797155, a NA study of Tobacco Use, has completed, sponsored by Oregon Research Behavioral Intervention Strategies.
- COMPLETED
- Registry status
- NA
- Development phase
- 437 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study aims to develop a cognitive dissonance-based mobile app for smoking cessation (Support2Quit) and test the efficacy of the app with 500 adult smokers who express a desire to quit smoking.
Primary Outcome
Based on 1-item that asked "In the past 7 days, have you smoked any cigarettes?". The variable is coded 1 if they the participants indicated they did not smoke any cigarettes otherwise coded 0. A value of 1 = abstinence and 0 = not abstinent.
Conditions Studied
Interventions
- BEHAVIORAL Support2Quit App - Cognitive Dissonance Based Smoking Cessation + Smoking Cessation Tips
- BEHAVIORAL Tips for Smoking Cessation App
Study Locations (1)
Oregon
- Oregon Research Behavioral Intervention Strategies, Inc. - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 437 participants |
| Start Date | 2023-12-01 |
| Est. Completion | 2025-03-15 |
| Phase | NA |
What the finished NCT05797155 record still lists
NCT05797155 is an interventional study that assigns participants to a tested intervention. The registered 437 participants enrollment target is mid-sized for trials with a published cap, above the 373-participant average among 76 other Tobacco Use trials with a reported enrollment target (17% higher).
The record links to 1 condition, with Tobacco Use appearing as the primary indexed condition, and to 2 interventions - of which Support2Quit App - Cognitive Dissonance Based Smoking Cessation + Smoking Cessation Tips is the first listed.
NCT05797155 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT05797155 about?
NCT05797155 is a clinical study titled "A Mobile App Based Cognitive Dissonance Intervention for Smoking Cessation". This research study aims to develop a cognitive dissonance-based mobile app for smoking cessation (Support2Quit) and test the efficacy of the app with 500 adult smokers who express a desire to quit smoking.
What is the current status of trial NCT05797155?
This trial is currently completed. It is a NA study. The enrollment target is 437 participants. The study started on 2023-12-01. Estimated completion is 2025-03-15.
What conditions does trial NCT05797155 study?
This clinical trial studies the following conditions: Tobacco Use.
What interventions are being tested in trial NCT05797155?
The interventions under investigation include: Support2Quit App - Cognitive Dissonance Based Smoking Cessation + Smoking Cessation Tips (BEHAVIORAL), Tips for Smoking Cessation App (BEHAVIORAL).
Who is sponsoring clinical trial NCT05797155?
This trial is sponsored by Oregon Research Behavioral Intervention Strategies, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05797155 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05797155's enrollment target sits among peer trials
437 14th of 76 higher than 63 of 76 other Tobacco Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Opioids, Low Nicotine Cigarettes, and Chronic Pain
RECRUITING · NA
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05711446 · 438 participants · NA
Double Voiding and Post-transplant UTI
- NCT02622542 · 436 participants · NA
ACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy
- NCT05918211 · 436 participants · Phase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
- NCT06966479 · 436 participants · Phase 2
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI